J.B. Chemicals & Pharmaceuticals Company Profile - Aug 19, 2011

Document Sample
J.B. Chemicals & Pharmaceuticals  Company Profile - Aug 19, 2011
Company Fundamentals\Company Profile



A Wright Investors' Service Research Report:



J.B. Chemicals & Pharmaceuticals Ltd

440 Wheelers Farms Road

Milford, CT 06461 U.S.A.





COMPANY PROFILE

Figures in Indian Rupees



Wright Quality Rating:DAB13 Key Data



J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL) is an India-based pharmaceutical Ticker:

company that manufactures and markets a range of pharmaceutical formulations, 506943

bulk drugs, intermediates, radio-diagnostics, herbal remedies and active

pharmaceutical ingredients (APIs). JBCPL exports its products to countries 2011 Sales:

worldwide, including South Africa, other South African countries and South-East

8,475,807,000

Asian countries. The Company's brands include Doktor Mom, Metrogyl, Rantac,

Nicardia Retard, Dicloran and Cilacar. Its API's products include Atenolol USP,

Ciprofloxacin Hydrochloride USP, Cilnidipine, Diclofenac Acid, Diclofenac Diethylamine Major Industry:

BP, Gadopentatic Acid and Diclofenac Sodium BP. JBCPL's formulation products Drugs, Cosmetics & Health

include Detrax, Vermorex, Ofloxacin, Metronidazole, Metrogyl, Zithrocin and Cefjoy. Care

Stock Chart Officers

Chairman & Managing Sub Industry:

Director Ethical Drug Manufacturers

Jyotindra B. Mody

Country:

President & Executive India

Director

Pranabh D. Mody Currency:

Indian Rupees

Secretary & Chief

Compliance Officer

Fiscal Year Ends:

Mayur C. Mehta

March



Employees

2,708



Exchanges:

BOM



Share Type:

Stock Price (8/12/2011): 148.10 Ordinary

Recent stock performance

1 Week 9.2%


By registering with docstoc.com you agree to our
privacy policy and terms of service

Successfully added document to cart!

Successfully added document to cart!